Lupin Goa facility gets 7 USFDA observations ruchika20 Sep 2021 7:11 AM GMTMumbai: Global Pharma major, Lupin, has recently announced that the United States Food and Drug Administration (USFDA) has concluded an inspection with...
Lupin unveils generic Duexis tablets in US ruchika16 Sep 2021 6:01 AM GMTMumbai: Global pharma major, Lupin Limited, has recently announced the launch of the authorized generic version of Duexis (ibuprofen and famotidine) Ta...
Lupin, TB Alliance parnter for anti-TB drug Pretomanid ruchika7 Sep 2021 6:33 AM GMTMumbai: Non-profit drug developer, TB Alliance has recently granted global pharma major Lupin Limited, a non-exclusive license to manufacture the anti-...
Lupin launches asthma, COPD drug Luforbec in UK ruchika24 Aug 2021 11:43 AM GMTLuforbec is first branded generic alternative to Fostair 100/6 g pMDI for treatment of Asthma and COPD.
Lupin gets USFDA nod for partial-onset seizures drug Brivaracetam ruchika17 Aug 2021 5:54 AM GMTMumbai: Global pharma major, Lupin Limited, has recently announced that the company has received tentative approval from the United States Food and Dru...
Lupin acquires Southern Cross Pharma in Australia Medical Dialogues Bureau31 July 2021 7:51 AM GMTLupin said as a part of the transaction, Generic Health will gain access to over 60 registered products having sales of over AUD 30 million...
Lupin launches generic equivalent of Kerydin Topical Solution in US ruchika14 July 2021 6:00 AM GMTMumbai: Global pharma major, Lupin Limited, has announced the US launch of Tavaborole Topical Solution, 5% having received an approval from the United ...
Lupin gets USFDA nod to expand Solosec use for Trichomoniasis ruchika2 July 2021 7:30 AM GMTBaltimore: Pharma major, Lupin Pharmaceuticals, has recently announced that the U.S. Food and Drug Administration (FDA) has approved the company's supp...
Lupin bags USFDA nod for Dolutegravir, Lamivudine, Tenofovir Disoproxil Fumarate Tablets under PEPFAR ruchika30 Jun 2021 11:43 AM GMTMumbai: Global pharma major, Lupin Limited, today announced that the company has received tentative approval from the United States Food and Drug Admin...
Lupin gets USFDA nod for generic equivalent of Renagel Tablets ruchika18 Jun 2021 7:15 AM GMTSevelamer Hydrochloride Tablets are indicated for the control of serum phosphorous in patients with chronic kidney disease (CKD) on dialysis.
Lupin gets UK marketing authorization for first branded generic of Fostair ruchika15 Jun 2021 7:46 AM GMTMumbai: Global pharma major, Lupin Limited, has recently announced that the company's UK subsidiary, Lupin Healthcare (UK) Limited has received approva...
Lupin New Jersey facility gets USFDA warning letter ruchika14 Jun 2021 6:25 AM GMTMumbai: Drug major, Lupin, has recently announced that the company has received a warning letter from the USFDA for its Somerset, New Jersey facility. ...
